MiraBiologics Inc.

News archive

November 26, 2020InformationNEW
Nov 20:  A paper on Lassograft Technology by Prof. Junichi Takagi, Osaka University, and Prof. Hiroaki Suga, University of Tokyo, was published in the Preprint (a Nature Research journal).
June 29, 2020Information
Jun 29:  Our company has been selected for NEDO’s (New Energy and Industrial Technology Development Organization) FY2020 “Research and Development Venture Support Program / Commercialization Support for Research and Development Ventures at Seed Stage”. The title of the grant is “Verification of the Pharmaceutical Properties of Met Agonists for the Treatment of NASH” and we will promote our own development project.
January 27, 2020Information
Feb 8 [Japanese Only] President Kato appeared at BS Fuji “konokuninoyukusue2 (every Saturday from 18:00 to 18:30)”, introduced our business (Part 2).
January 27, 2020Information
Feb 1 [Japanese Only] President Kato appeared at BS Fuji “konokuninoyukusue2 (every Saturday from 18:00 to 18:30)”, introduced our business (Part 1).
January 17, 2020Information
Jan. 15: Notice Concerning Third Party Allocation / In order to further accelerate the business, MiraBiologics Inc. announces the completion of 550 million Japanese Yen (US$ 5 Million, as of Jan. 10, 2020) private financing, led by Shinsei Capital Partners Ltd. as a lead investor, and , SMBC Venture Capital Co., Ltd, SBI Investment Co., Ltd.
January 10, 2020Information
Nov. 28: At the “Forbes JAPAN CEO Conference” hosted by Forbes JAPAN, we received the “Mizuho Award”, a special award at the “Japanese Entrepreneurs Ranking” award ceremony (PDF attached, Japanese only).
January 10, 2020Information
Nov. 14: We assented Kanagawa Prefectural Tama High School’s Super Science High school (SSH) initiative and accepted Tama High School’s company visit as an SDGs initiative. (attached to PDF, Japanese only).
January 10, 2020Information
Oct. 11: A patent for which an exclusive license agreement concluded with the University of Tokyo and Osaka University was registered in Japan (Patent No. 6598344). We are continuing the transition to each country.
January 10, 2020Information
Sep. 20: Ms. Mihara of Osaka University Takagi Laboratory, our joint research partner, gave a presentation on LassoGraft Technology at the 92nd Annual Meeting of the Biochemical Society of Japan, Symposium “New Biopharmaceutical Innovation from Japan,” (PDF attached, Japanese only).
June 17, 2019Information
Jun 23 (Sun) 15:00, Prof. Junichi Takagi had a talk session at the 5th Workshop on “Industrial Development and Structural Biology” in Kobe.